Roivant does not view - and has never viewed - Axovant as simply a 'vehicle' for developing intepirdine, but instead as a platform for the development of high-impact drugs in dementia and the neuroscience field more generally.

Vivek Ramaswamy

Biography

Author Profession: Businessman
Nationality: American
Born: August 9, 1985

Links

Find on Amazon: Vivek Ramaswamy
Cite this Page: Citation

Quotes to Explore